<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0"><channel><title>Emtricitabine/Tenofovir disoproxil Krka d.d. RSS feed</title><ttl>1440</ttl><copyright>Copyright: (C) European Medicines Agency</copyright><language>en-gb</language><lastBuildDate>Thu, 13 Jul 2017 19:47:31 +0100</lastBuildDate><link>http://www.ema.europa.eu</link><description>Emtricitabine/Tenofovir disoproxil Krka d.d. RSS feed</description><item><title>Human medicines European Public Assessment Report (EPAR): Emtricitabine/Tenofovir disoproxil Krka d.d., emtricitabine / tenofovir disoproxil succinate, Revision: 1, Authorised</title><guid isPermaLink="true">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004686/human_med_002091.jsp&amp;mid=WC0b01ac058001d124</guid><link>http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004686/human_med_002091.jsp&amp;mid=WC0b01ac058001d124</link><description><![CDATA[]]></description><pubDate>Wed, 12 Jul 2017 00:00:00 +0100</pubDate></item><item><title>Emtricitabine/Tenofovir disoproxil Krka d.d. : EPAR - Procedural steps taken and scientific information after authorisation</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation/human/004686/WC500231224.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Procedural_steps_taken_and_scientific_information_after_authorisation/human/004686/WC500231224.pdf</link><description><![CDATA[]]></description><pubDate>Wed, 12 Jul 2017 00:00:00 +0100</pubDate></item><item><title>Emtricitabine/Tenofovir disoproxil Krka d.d. : EPAR - Product Information</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004686/WC500229219.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004686/WC500229219.pdf</link><description><![CDATA[]]></description><pubDate>Wed, 12 Jul 2017 00:00:00 +0100</pubDate></item><item><title>Emtricitabine/Tenofovir disoproxil Krka d.d. : EPAR - Public assessment report</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004686/WC500229221.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004686/WC500229221.pdf</link><description><![CDATA[]]></description><pubDate>Fri, 09 Jun 2017 00:00:00 +0100</pubDate></item><item><title>Emtricitabine/Tenofovir disoproxil Krka d.d. : EPAR - Summary for the public</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004686/WC500229222.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004686/WC500229222.pdf</link><description><![CDATA[]]></description><pubDate>Fri, 09 Jun 2017 00:00:00 +0100</pubDate></item><item><title>Emtricitabine/Tenofovir disoproxil Krka d.d. : EPAR - All Authorised presentations</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004686/WC500229220.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_All_Authorised_presentations/human/004686/WC500229220.pdf</link><description><![CDATA[]]></description><pubDate>Fri, 09 Jun 2017 00:00:00 +0100</pubDate></item><item><title>CHMP summary of positive opinion for Emtricitabine/Tenofovir disoproxil Krka d.d.</title><guid isPermaLink="true">http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004686/WC500222149.pdf</guid><link>http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004686/WC500222149.pdf</link><description><![CDATA[]]></description><pubDate>Fri, 24 Feb 2017 00:00:00 +0000</pubDate></item><item><title>News and Press Releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 February 2017</title><guid isPermaLink="true">http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/02/news_detail_002698.jsp&amp;mid=WC0b01ac058004d5c1</guid><link>http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/02/news_detail_002698.jsp&amp;mid=WC0b01ac058004d5c1</link><description><![CDATA[Six medicines recommended for approval, including one orphan]]></description><pubDate>Fri, 24 Feb 2017 00:00:00 +0000</pubDate></item></channel></rss>